首页> European journal of gastroenterology & hepatology> Risk factors and clinical course of inflammatory bowel disease in patients receiving cancer therapy.

Risk factors and clinical course of inflammatory bowel disease in patients receiving cancer therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cristina,Natha

第一单位： Department of Internal Medicine, The University of Texas Health Sciences Center.

作者： Cristina,Natha ^[1] ; Carolina,Colli Cruz ^[2] ; Varun,Vemulapalli ^[1] ; Andrew,Sullivan ^[1] ; Sidra,Naz ^[2] ; Rohan,Ahuja ^[1] ; Kazi,Haque ^[1] ; Emily,Zhou ^[1] ; Jasmine,Haydel ^[3] ; Nina,Quirk ^[1] ; Sharada,Wali ^[2] ; Kei,Takigawa ^[3] ; Pooja,Prasad ^[3] ; Arjun,Peddireddy ^[1] ; Kevin,Shi ^[1] ; Eric,Lu ^[2] ; Andrew Ming-Chung,Lee ^[2] ; Maria,Julia Moura Nascimento Santos ^[2] ; Kristin,Junek ^[2] ; Ninoska,Silva ^[2] ; Aliyah,Pabani ^[4] ; Jessica,Philpott ^[5] ; Anusha S,Thomas ^[2] ; Yinghong,Wang ^[2]

作者单位： Department of Internal Medicine, The University of Texas Health Sciences Center. ^[1] Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center. ^[2] Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. ^[3] Department of Oncology, Johns Hopkins University, Baltimore, Maryland. ^[4] Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA. ^[5]